Kennedy Capital Management LLC Buys 565,445 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)

Kennedy Capital Management LLC increased its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 42.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,891,000 shares of the company's stock after acquiring an additional 565,445 shares during the quarter. Kennedy Capital Management LLC owned approximately 3.11% of Health Catalyst worth $13,369,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Raymond James Financial Inc. bought a new position in shares of Health Catalyst during the 4th quarter worth about $2,044,000. Envestnet Asset Management Inc. boosted its holdings in Health Catalyst by 92.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 33,773 shares of the company's stock worth $239,000 after acquiring an additional 16,208 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Health Catalyst in the fourth quarter valued at approximately $232,000. Wells Fargo & Company MN increased its holdings in shares of Health Catalyst by 27.3% during the fourth quarter. Wells Fargo & Company MN now owns 39,355 shares of the company's stock valued at $278,000 after acquiring an additional 8,451 shares in the last quarter. Finally, ExodusPoint Capital Management LP acquired a new position in shares of Health Catalyst during the fourth quarter worth approximately $107,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Health Catalyst

In other Health Catalyst news, COO Daniel Lesueur sold 16,902 shares of the company's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $4.52, for a total transaction of $76,397.04. Following the sale, the chief operating officer now directly owns 216,250 shares of the company's stock, valued at $977,450. This represents a 7.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Linda Llewelyn sold 6,442 shares of Health Catalyst stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $5.80, for a total transaction of $37,363.60. Following the completion of the transaction, the insider now owns 92,260 shares of the company's stock, valued at $535,108. The trade was a 6.53 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 54,030 shares of company stock worth $263,269. Insiders own 2.50% of the company's stock.

Wall Street Analysts Forecast Growth

HCAT has been the subject of several research reports. Citigroup reduced their price target on shares of Health Catalyst from $10.50 to $10.00 and set a "buy" rating for the company in a research report on Friday, January 10th. Canaccord Genuity Group lowered their target price on shares of Health Catalyst from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Tuesday, January 21st. Stifel Nicolaus cut their price target on Health Catalyst from $10.00 to $5.00 and set a "hold" rating for the company in a research note on Thursday, February 27th. Royal Bank of Canada lowered their price objective on Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating for the company in a research note on Thursday, February 27th. Finally, Wells Fargo & Company cut their target price on Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $8.73.

Health Catalyst Stock Performance

HCAT traded down $0.07 during midday trading on Tuesday, reaching $3.77. The company had a trading volume of 91,828 shares, compared to its average volume of 614,140. Health Catalyst, Inc. has a 12-month low of $3.60 and a 12-month high of $9.24. The business has a 50-day moving average price of $4.61 and a two-hundred day moving average price of $6.46. The stock has a market cap of $264.70 million, a PE ratio of -2.79 and a beta of 1.43. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.